Rafferty Asset Management
NERV icon

Rafferty Asset Management’s Minerva Neurosciences NERV Stock Holding History

Rafferty Asset Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,108
Closed -$85K – 1317
2021
Q3 		$85K Buy
+6,108
New +$91.9K ﹤0.01% 1241

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Rafferty Asset Management's NERV Position: Q4 2021 in Review

Rafferty Asset Management sold out of Minerva Neurosciences (NERV) in Q4 2021, closing a stake of 6,108 shares — an estimated $85K sold.

Rafferty Asset Management first reported a position in NERV in Q3 2021 and held it in 1 quarter. The position peaked at $85K in Q3 2021. 35 funds tracked by Wall St. Rank hold NERV as of Q4 2021.

  • Rafferty Asset Management reported no remaining Minerva Neurosciences position as of Q4 2021 after selling out during the quarter.
  • Rafferty Asset Management sold 6,108 Minerva Neurosciences shares in Q4 2021, an estimated $85K.
  • Rafferty Asset Management first reported a position in Minerva Neurosciences in Q3 2021 and held it in 1 quarter.
  • Rafferty Asset Management's Minerva Neurosciences position peaked at $85K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2021.

Based on Rafferty Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.